Document is current
Any future updates will be listed below
-
Authors
Zhong, Yi https://orcid.org/0000-0002-0929-8224
Lauschke, Volker M. https://orcid.org/0000-0002-1140-6204
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2021-02801)
Vetenskapsrådet (2023-03015)
- License Information
-
More Information
Article History
Received: 28 August 2024
Revised: 27 September 2024
Accepted: 29 September 2024
First Online: 5 October 2024
Competing interests
: V.M.L. is co-founder, CEO and shareholder of HepaPredict AB, as well as co-founder and shareholder of Shanghai Hepo Biotechnology Ltd. Y.Z. does not have competing interests to declare.
